Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking
Andrea R. Shiakolas(Vanderbilt University Medical Center), Ivelin S. Georgiev(Vanderbilt University), Lauren Walker(Vanderbilt University Medical Center), Robert H. Carnahan(Vanderbilt University Medical Center), Alexander Bukreyev(Galveston College), Rachel E. Sutton(Vanderbilt University Medical Center), Nagarajan Raju(Vanderbilt University Medical Center), Daniel Wrapp(Duke University), James E. Crowe(Vanderbilt University Medical Center), Steven C. Wall(Vanderbilt University Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Naveenchandra Suryadevara(Vanderbilt University), Nicole V. Johnson(The University of Texas at Austin), Kevin J. Kramer(Vanderbilt University Medical Center), Ian Setliff(Vanderbilt University Medical Center), Sivakumar Periasamy(Albany Medical Center Hospital), Kelsey A. Pilewski(Vanderbilt University Medical Center), Jason S. McLellan(The University of Texas at Austin)
Cited by 56
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Site-specific glycan analysis of the SARS-CoV-2 spike
|Science|2020|1.7k
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
|Science|2020|1.4k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k